Supernus Pharmaceuticals buy melinda
Start price
25.01.21
/
50%
€25.20
Target price
25.01.22
€28.00
Performance (%)
3.97%
End price
26.01.22
€26.20
Summary
This prediction ended on 26.01.22 with a price of €26.20. The BUY prediction by melinda finished with a performance of 3.97%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Supernus Pharmaceuticals | 2.143% | 2.143% | 8.333% | 25.439% |
iShares Core DAX® | 1.510% | 2.268% | 18.541% | 18.577% |
iShares Nasdaq 100 | -0.271% | -1.533% | 22.755% | 34.901% |
iShares Nikkei 225® | -0.108% | 0.411% | 10.352% | -0.876% |
iShares S&P 500 | 0.479% | 0.563% | 22.881% | 38.847% |
According to melinda what are the pros and cons of Supernus Pharmaceuticals for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Supernus Pharmaceuticals diskutieren
Buy mit Kursziel 28,0
In the thread Trading Supernus Pharmaceuticals
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for Supernus Pharmaceuticals
Supernus Pharmaceuticals
Start price
Target price
Perf. (%)
€43.88
09.08.18
09.08.18
€53.94
09.08.19
09.08.19
-41.09%
09.08.19
09.08.19
Could be worthwhile Investment >10% per year
Supernus Pharmaceuticals
Start price
Target price
Perf. (%)
€6.88
27.01.14
27.01.14
€5.00
28.07.14
28.07.14
-1.37%
28.07.14
28.07.14
Could be worthwhile Investment >10% per year